These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1214539)

  • 21. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3 vaccines against influenza--which to choose].
    Holzner A; Stickl H
    Fortschr Med; 1979 Aug; 97(30-31):1305-10. PubMed ID: 468092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience in the study of the immunogenicity of killed influenza vaccine, purified and concentrated by the method of sorption chromatography].
    Malafeeva LK; Daĭter AB; Peradze TV; Fridman EA; Tentser PS
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():67-73. PubMed ID: 4808388
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influenza virus vaccines].
    Schell KR
    Schweiz Med Wochenschr; 1980 Apr; 110(14):510-22. PubMed ID: 6154970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
    Patel A; Tran K; Gray M; Li Y; Ao Z; Yao X; Kobasa D; Kobinger GP
    Vaccine; 2009 May; 27(23):3083-9. PubMed ID: 19428922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza: current concepts.
    Dolin R
    Am Fam Physician; 1976 Sep; 14(3):72-7. PubMed ID: 961563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: Inactivated influenza vaccines.
    Dowdle WR
    N Engl J Med; 1973 Dec; 289(24):1309-10. PubMed ID: 4127184
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccination strategy in influenza].
    Niculescu IT; Zilişteanu E; Creţescu L; Oprescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(3):129-35. PubMed ID: 128101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the reactogenic and immunogenic properties of killed influence vaccine purified and concentrated by the method of adsorbed chromatography on silicate sorbents].
    Peradze TV; Fridman EA; Kolikov VM; Bichurina MA; Goriunova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):18-22. PubMed ID: 1015075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with Czechoslovak subunit anti-influenza vaccine (author's transl)].
    Závadová H; Vonka V; Stárek M; Domorázková E; Bruj J; Skocil V
    Cas Lek Cesk; 1975 Nov; 114(47):1462-6. PubMed ID: 1203931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of unspecific inhibitors of hemagglutination in the course of immunization with live and inactivated influenza viruses].
    Zgorzelska K; Semkow R
    Med Dosw Mikrobiol; 1977; 29(2):107-11. PubMed ID: 895249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.